Solutions for Biotherapeutic Intact Mass Analysis

Significance of the Topic

The intact mass analysis of biotherapeutics is a cornerstone in modern analytical chemistry, providing critical information on molecular identity, post-translational modifications and glycosylation profiles. Reliable mass assignments and robust workflows accelerate decision-making during biologic development and quality control, reducing cycle times and improving product consistency.

Objectives and Study Overview

This whitepaper describes simplified, streamlined solutions for intact-mass characterization of therapeutic proteins and antibody-drug conjugates (ADCs) using the SCIEX X500B QTOF and TripleTOF 6600 platforms. It aims to demonstrate high mass accuracy, ease-of-use for non-experts, and integration with powerful data processing software.

Instrumentation Used

• SCIEX X500B QTOF system with Turbo V™ ion source and heated TOF flight path for enhanced stability and sensitivity
• SCIEX OS software interface for point-and-click method setup, queue management and real-time data review
• BioPharmaView™ 2.0 for automated intact protein deconvolution, glycoform analysis and drug-antibody ratio (DAR) calculations
• SCIEX TripleTOF® 6600 system paired with CESI 8000 Plus capillary electrophoresis module for high-resolution separation
• SelexION® differential mobility spectrometry (DMS) device for background reduction in complex ADC samples

Main Results and Discussion

The X500B QTOF achieved sub-5 ppm mass accuracy over extended sequences of injections, clearly resolving major and minor glycoforms of monoclonal antibodies. Automated subunit analysis following IdeS digestion enabled confident identification of Fc and F(ab')2 regions and associated PTMs. Integration with BioPharmaView software provided rapid intact mass deconvolution and automated DAR calculations, reducing manual processing time. Coupling CESI separations to TripleTOF 6600 further improved detection of low-abundance proteoforms and clipped variants in ADCs.

Benefits and Practical Applications

• Non-expert accessibility: simplified software interface and guided workflows lower the barrier for routine intact mass characterization
• High confidence data: robust calibration and heated TOF path ensure stable mass accuracy across long sequences
• Automated reporting: one-click batch processing and linked raw-to-deconvoluted data visualization streamline QC and comparability studies
• Comprehensive ADC analysis: SelexION DMS and DAR automation enable accurate quantitation of drug loading in complex matrices

Future Trends and Potential Applications

Emerging trends include deeper integration of orthogonal separations (CESI, ion mobility) with advanced mass analyzers to enhance proteoform resolution at lower sample volumes. Real-time, in-process monitoring of biologic manufacturing and AI-driven data analytics will further automate quality assessment. Continued development of user-friendly interfaces and cloud-based processing will expand accessibility in regulated QC environments.

Conclusion

The SCIEX X500B QTOF and TripleTOF platforms, combined with SCIEX OS and BioPharmaView software, deliver a powerful, streamlined solution for intact mass analysis of biotherapeutics and ADCs. Their high accuracy, robustness and ease of use enable researchers and QA/QC laboratories to obtain reliable insights faster and with greater confidence, paving the way for improved biologic development workflows.